Astrea Bioseparations News and Activities

Astrea Bioseparations is owned by Gamma Biosciences. Gamma Biosciences has a direct presence in 2 countries.

They are in:

• Biotechnology67%
• Medical Equipment33%

View the org chart displaying its 7 main executives

Most searched biographies at Astrea Bioseparations

• Terry Pizzie, Chief Executive Officer
• Steve Burton, President and Chief Scientific Officer
• Andrew Kellett, Chief Financial Officer

Popular executive movements at Astrea Bioseparations

• Chris Brown, who was Operations Director, is promoted to Commercial and Operations Director  (posted on February 7 2025).
• Gabe Longoria, Chief Commercial Officer, has left the company  (posted on February 7 2025).
• Nicol Watson, Vice President, Corporate & Market Strategy, has left the company  (posted on February 7 2025).

Create your alert
to follow the executive moves at Astrea Bioseparations.

Gamma Biosciences has 2,339 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Biogen (United States (USA)).

Popular M&A news in Biotechnology

• Stylus Medicine has just announced a $85 Million fundraising (posted on May 16 2025).
• Azafaros has just announced a $132 Million fundraising (posted on May 15 2025).
• The new name of Garuda Therapeutics is Stratus Therapeutics. (posted on May 12 2025).

Popular contacts in Biotechnology

• Sandra Smith - Senior Vice President, Clinical Solutions & Strategic Partnerships at WIRB-Copernicus Group
• Deepika Verma - Associate Director of Data Science and Digitalization at Wheeler Bio
• Steven Gillis - Chairman of the Board at VBI Vaccines

Learn more about the Biotechnology industry

Press releases by Astrea Bioseparations

Social media about Astrea Bioseparations

• Astrea Bioseparations on Wikipedia, Google News & Yahoo Finance
• Astrea Bioseparations on LinkedIn, Twitter & YouTube